Columbia University researchers developed an injectable omega-3 emulsion that reduced brain damage in newborn rodents due to oxygen deprivation, potentially improving outcomes for hypoxic brain injury patients.

Columbia University researchers developed an injectable omega-3 emulsion that significantly reduced brain damage in newborn rodents due to oxygen deprivation during birth. The omega-3 therapy, more effective than current standard therapy therapeutic hypothermia, may lead to improved outcomes for hypoxic brain injury patients. Clinical trials in newborns are planned within two years.

June 06, 2024
5 Articles

Further Reading